Royalty Pharma establishes $500M revolving credit facility with major banks
Royalty Pharma plc entered into a revolving credit agreement dated May 22, 2026 with Bank of America and other major financial institutions. The facility provides liquidity support for the pharmaceutical royalty company's operations and strategic initiatives.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day